Showing 2611-2620 of 9943 results for "".
Top 2023 Psoriasis Treatment Announcements
https://practicaldermatology.com/topics/psoriasis/top-2023-psoriasis-treatment-announcements/20232/Daniel Schlessinger, MD, Mohs Micrographic Surgery and Cosmetic Dermatology Fellow at Northwestern University, reviews for Practical Dermatology® some of the important psoriasis drug approval news of 2023.Dermatology Innovations
https://practicaldermatology.com/topics/psoriasis/dermatology-innovations/20044/From topical therapies to JAK inhibitors, there are many new drugs available to treat a wide variety of dermatologic conditions. Neal Bhatia, MD reviews what's new for atopic dermatitis, alopecia areata, scabies, lice, onychomycosis, and more. Plus, he discusses the importance of new delivery systemDermWireTV: NPF on Boosters; Galderma Raises Awareness, World Eczema Day, and more
https://practicaldermatology.com/topics/psoriasis/dermwiretv-npf-on-boosters-galderma-raises-awareness-world-eczema-day-and-more/20002/Launched on World Eczema Day, the Global Patient Initiative to Improve Eczema Care represents 11 patient organizations from eight countries. The initiative is supported with funding from LEO Pharma. GlobalSkin marked World Eczema Day by calling on health care professionals, health policy decision maFive easy ways to increase your clickthrough rate
https://practicaldermatology.com/topics/practice-management/five-easy-ways-to-increase-your-clickthrough-rate/19956/Your dermatology website’s placement on the Google search results page is important – but it is not everything. Check out this short video from Ekwa Marketing to discover a few simple ways to improve traffic, no matter where your link is on the search page.DermWireTV: 2020 in Review
https://practicaldermatology.com/topics/psoriasis/dermwiretv-2020-in-review/19882/Crisaborole ointment became the first and only steroid-free, topical prescription medication for mild to moderate AD in patients as young as three months of age. Ustekinumab is approved for pediatric patients with moderate to severe plaque psoriasis. FDA approved ixekizumab injection, 80mg/mL for tConsidering Aesthetic Combinations
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/considering-aesthetic-combinations/19684/Whether it's the use of two or more devices or the addition of fillers or neurotoxins to device-based treatments, combination approaches can improve outcomes and potentially reduce downtime, Nazanin Saedi, MD explains.Psoriasis Risk Factors and Comorbidities
https://practicaldermatology.com/topics/psoriasis/psoriasis-risk-factors-and-comorbidities/19650/Ronald Prussick, MD outlines known risk factors for developing psoriasis, such as genetic factors, smoking, alcohol consumption, and increased BMI, and recent studies that confirm these risks. He also shares data on comorbidities, including the patients with psoriasis are more prone to pathologic frTherapeutic Advancements in Dermatology
https://practicaldermatology.com/topics/psoriasis/therapeutic-advancements-in-dermatology/18347/What therapeutic innovations define the specialty of dermatology? From significant strides in managing STDs and battling skin cancer to the harnessing of retinoids and the integration of biologics, dermatology has remained at the leading edge of medicine. Take a look at the specialty's top advancemeIs Your Financial Advisor Working for You
https://practicaldermatology.com/topics/practice-management/is-your-financial-advisor-working-for-you/18367/OJM Group Wealth Advisor, Andrew Taylor, CFP discusses the importance of working with an advisor with a "fiduciary" vs. "suitability" standard, and outlines other questions to ask when determining if your advisor is working in your best interest. Click here to request or download a free copy of WealMid-Face Filler Pearls
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/mid-face-filler-pearls/18537/Shannon Humphrey, MD shares three pearls for avoiding the filler complication patients fear the most in the mid-face: unnatural results. You must have a plan, she says, to avoid treating the cheeks as an island rather than as part of the full face.